FindTrial
Sign In

Bacteriology of pustular acne and evaluation of the efficacy of systemic azithromycin and minocycline in pustular acne

Bacteriology of pustular acne and evaluation of the efficacy of systemic azithromycin and minocycline in pustular acne

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/07/003856
Enrollment
40
Registered
2013-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ACNE VULGARIS

Interventions

Control Intervention1: TABLET AZITHROMYCIN: ORAL 500MG ONCE DAILY FOR THREE DAYS PER WEEK FOR 6 WEEKS Control Intervention2: TABLET MINOCYCLINE: ORAL 100MG DAILY FOR 6 WEEKS

Sponsors

DR REEJA MARIAM GEORGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age above 14 years and of both sexes. 2. Patients having pustular acne vulgaris. 3. Patients willing to undergo treatment and to come for follow up.

Exclusion criteria

Exclusion criteria: 1. Age less than 14 years. 2. Patients having other presentations of acne vulgaris. 3. Pregnant women and women who intend to become pregnant during the course of the treatment. 4. Presence of any known renal or hepatic disease. 5. Patients not willing for necessary investigations

Design outcomes

Primary

MeasureTime frame
identify the aerobic and anaerobic bacteria in pustular acneTimepoint: 4—

Secondary

MeasureTime frame
to evaluate the efficacy of oral azithromycin and minocycline in pustular acneTimepoint: 4—

Countries

India

Contacts

Public ContactDR RAMESH BHAT M

FATHER MULLER MEDICAL COLLEGE AND HOSPITAL

RAMESHDERMA@YAHOO.COM

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026